Expanded non-genetically modified natural killer cells (troculeucel) with enhanced cytotoxicity in moderate/advanced Alzheimer's disease. Scientific rationale with preliminary clinical and biomarker results

Key Points

• Enhanced cytotoxicity of troculeucel showed significant potential in targeting Alzheimer's disease-related cells.
• Biomarker results indicate a promising response from moderate to advanced Alzheimer's disease patients during the analysis.
• Assessment using natural killer cells enhanced through a specific protocol highlights a new therapeutic strategy.
• Further studies are needed to validate the findings and expand the understanding of this treatment's efficacy against Alzheimer's disease.